Modulation of α-smooth muscle actin expression in fibroblasts by transforming growth factor-β isoforms: An in vivo and in vitro study

Wound Repair and Regeneration

Volumn 4, Issue 2, 1996, Pages 278-287

  Serini, Guido ^a   Gabbiani, Giulio ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18844382639     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.1996.40217.x     Document Type: Article

References (68)

1. Desmoulière A, Gabbiani G. Myofibroblast differentiation during fibrosis. Exp Nephrol 1995;3:134-9.
2. Skalli O, Schürch W, Seemayer T, Lagace R, Montandon D, Pittet B, Gabbiani G. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 1989;60:275-85.
3. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-9.
4. Schürch W, Seemayer TA, Gabbiani G. Myofibroblast. In: Sternberg SS, editor. Histology for pathologists. New York: Raven Press, 1992:109-44.
5. Desmoulière A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
6. Ehrlich HP, Desmoulière A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, Gabbiani G. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994;145:105-13.
7. Roberts AB, Sporn MB. The transforming growth factors-β. In: Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors. Berlin: Springer-Verlag, 1990:419-72.
8. Sporn MB, Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol 1992;119:1017-21.
9. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 1993;8:1-9.
10. Cox DA. Transforming growth factor-beta 3. Cell Biol Int 1995;19:357-71.
11. Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, Derynck R. Human transforming growth factor-β3: recombinant expression, and biological activities in comparison with transforming growth factors-β1 and -β2. Mol Endocrinol 1989;3:1977-86.
12. Pelton RW, Johnson MD, Perkett EA, Gold LI, Moses HL. Expression of transforming growth factor-β1, -β2, and -β3 mRNA and protein in the murine lung. Am J Respir Cell Mol Biol 1991;5:522-30.
13. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGF-β1, TGF-β2, and TGF-β3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991;115:1091-105.
14. Shah M, Foreman DM, Ferguson MWJ. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992;339:213-4.
15. Ksander GA, Chu GH, McMullin H, Ogawa Y, Pratt BM, Rosenblatt JS, Mc Pherson JM. Transforming growth factors-β1 and -β2 enhance connective tissue formation in animal models of dermal wound healing by secondary intent. Ann NY Acad Sci 1990;593:135-47.
16. Ksander GA, Ogawa Y, Chu GH, McMullin H, Rosenblatt JS, JM McPherson. Exogenous transforming growth factor-β2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent. Ann Surg 1990;211:288-94.
17. Mustoe TA, Landes A, Cromack DT, Mistry D, Griffin A, Deuel TF, Pierce GF. Differential acceleration of healing of surgical incisions in the rabbit gastrointestinal tract by platelet-derived growth factor and transforming growth factor, type β. Surgery 1990;108:324-9.
18. Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest 1991;87:694-703.
19. Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA. Transforming growth factor-β2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology 1992;99:1162-72.
20. Beck LS, De Guzman L, Lee WP, Xu Y, Siegel MW, Amento EP. One systemic administration of transforming growth factor-β1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest 1993;92:2841-9.
21. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103-11.
22. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.
23. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994;331:1286-92.
24. Levine JH, Moses HL, Gold LI, Nanney LB. Spatial and temporal patterns of immunoreactive transforming growth factor-β1, -β2, and -β3 during excisional wound repair. Am J Pathol 1993;143:368-80.
25. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986;103:2787-96.
26. Kocher O, Skalli O, Bloom WS, Gabbiani G. Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimai thickening. Lab Invest 1984;50:645-52.
27. Lennette DA. An improved mounting medium for immunofluorescence microscopy. Am J Clin Pathol 1978;69:647-8.
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
29. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal Biochem 1976;72:248-54.
30. Kocher O, Skalli O, Cerutti D, Gabbiani F, Gabbiani G. Cytoskeletal features of rat aortic cells during development. An electron microscopic, immunohistochemical, and biochemical study. Circ Res 1985;56:829-38.
31. Towbin HT, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
32. Barrett TB, Benditt EP. Sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci U S A 1987;84:1099-103.
33. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
34. Rønnov-Jessen L, Petersen OW, Bissell MJ. The origin of myofibroblasts in breast cancer. J Clin Invest 1995;95:859-73.
35. Schmitt-Gräff A, Kruger S, Bochard F, Gabbiani G, Denk H. Modulation of a smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991;138:1233-42.
36. Johnson RJ, Lida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, Gown AM. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. α-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991;87:847-58.
37. Kapanci Y, Burgan S, Pietra GG, Conne B, Gabbiani G. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. Am J Pathol 1990;136:881-9.
38. Shum DT, McFarlane RM. Histogenesis of Dupuytren's disease: an immunohistochemical study of 30 cases. J Hand Surg [Am]. 1988;13A:61-7.
39. Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971;27:549-50
40. Ramadori G, Rieder H, Knittel T, Dienes HP, Meyer zum Buschenfelde KH. Fat storing cells of rat liver synthesize and secrete fibronectin. Comparison with hepatocytes. J Hepatol 1987;4:190-7.
41. Lieubeau B, Garrigue L, Barbieux I, Meflah K, Gregoire M. The role of transforming growth factor-β1 in the fibroblastic reaction associated with rat colorectal tumor development. Cancer Res 1994;54:6526-32.
42. Dimanche Boitrel MT, Vakaet LJ, Pujuguet P, Chauffert B, Martin MS, Hammann A, Van Roy F, Mareel M, Martin F. In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer 1994;56:512-21.
43. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;384:699-704.
44. Rubbia-Brandt L, Sappino AP, Gabbiani G. Locally applied GM-CSF induces the accumulation of α-smooth muscle actin containing myofibroblasts. Virchows Arch B 1991;60:73-82.
45. Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA. Immunohistochemical staining for transforming growth factor-β1 associates with disease progression in human breast cancer. Cancer Res 1992;52:6949-52.
46. Gold LI, Saxena B, Mittal KR, Marmor M, Goswami S, Nactigal L, Korc M, Demopoulos RI. Increased expression of transforming growth factor-β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 1994;54:2347-58.
47. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold DJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992;359:693-9.
48. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-4.
49. Kulkarni AB, Ward JM, Yaswen L, Mackall CL, Bauer SR, Huh CG, Gress RE, Karlsson S. Transforming growth factor-β1 null mice. An animal model for inflammation disorders. Am J Pathol 1995;146:264-75.
50. Boivin GP, O'Toole BA, Orsmy IE, Diebold RJ, Eis MJ, Doetschman T, Kier AB. Onset and progression of pathological lesions in transforming growth factor-β1-deficient mice. Am J Pathol 1995;146:276-88.
51. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MWJ, Doetschman T. Transforming growth factor-β3 is required for secondary palate fusion. Nature Genet 1995;11:409-14.
52. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nature Genet 1995;11:415-21.
53. Shah M, Foreman DM, Ferguson MWJ. Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:985-1002.
54. Burrington, JD. Wound healing in fetal lamb. J Pediatr Surg 1971;6:523-7.
55. Goss AN. Intrauterine healing of fetal rat oral mucosa, skin, and cartilage. J Oral Pathol 1977;6:35-8.
56. Adzick NS, Harrison MR, Glick PL, Beckstaed JL, Villa RL, Scheuenstuhl H, Goodson WH. Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. J Pediatr Surg 1985;20:315-9.
57. Rowsell AR. The intra-uterine healing of fetal muscle wounds: experimental study in the rat. Br J Plast Surg 1986;37:635-42.
58. Krummel TM, Nelson JM, Diegelmann RF, Lindblad WJ, Salzberg AM, Greenfield LJ, Cohen IK. Fetal response to injury in the rabbit. J Pediatr Surg 1987;22:640-4.
59. Adzick NS. Scarless fetal wound healing: therapeutic implications. Ann Surg 1992;215:3-7.
60. Estes JM , Vande Berg JS, Adzick NS, MacGillivray TE, Desmoulière A, Gabbiani G. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 1994;56:173-81.
61. Blaschke RJ, Howlett AR, Desprez PY, Petersen OW, Bissell MJ. Cell differentiation by extracellular matrix components. Meth Enzymol 1994;245:535-56.
62. Boudreau N, Myers C, Bissell MJ. From laminin to lamin: regulation of tissue-specific gene expression by the extracellular matrix. Trends Cell Biol 1995;5:1-4.
63. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994;124:401-4.
64. Clarke EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995;268:233-9.
65. Roskelley CD, Srebrow A, Bissel MJ. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol 1995;7:736-47.
66. Streuli CH, Schmidhauser C, Kobrin M, Bissel MJ, Derynck R. Extracellular matrix regulates expression of the TGF-β1 gene. J Cell Biol 1993;120:253-60.
67. Balza E, Borsi L, Allemanni G, Zardi L. Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett 1988;228:42-4.
68. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127:2037-48.